Tech Company Financing Transactions
NexCure Funding Round
RA Capital Management, Cencora Ventures and Oncology Impact Fund participated in a $19 million Series A funding round for NexCure. The round was announced on 3/5/2026.
Transaction Overview
Company Name
Announced On
3/5/2026
Transaction Type
Venture Equity
Amount
$19,000,000
Round
Series A
Investors
Proceeds Purpose
This financing will support NexCure as it builds out the operating system for clinically intensive therapy delivery, integrating clinical decision support, remote monitoring, and operational intelligence.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Berkeley Street, 18th Floor
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Undisclosed
Website
Email Address
Overview
NexCure partners with health systems to build and operate outpatient treatment centers--focusing on CAR-T and T-cell engagers. We build and operate innovative treatment centers to bring CAR-T and other advanced therapies closer to home. NexCure's platform integrates AI-powered patient selection, remote monitoring, and standardized clinical protocols to ensure every patient receives safe, compassionate, and personalized treatment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Paul Rothman
Chief Executive Officer
Jennifer Smith
Chief Marketing Officer
Sophie Papa
VP - Bus. Development
Anish More
Browse more venture capital transactions:
Prev: 3/5/2026: Sage venture capital transaction
Next: 3/5/2026: Reclaim Security venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record all VC transactions involving tech companies. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs